← Open Payments lookup

AMBER FONTAN: Open Payments

NPI 1841538030 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$349 in 19 payments from 8 companies in 2025. Trend: 2023 $280 · 2024 $418 · 2025 $349

Food & beverage: $349
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$143
ABBVIE INC.4$69
Novo Nordisk Inc2$36
Novartis Pharmaceuticals Corporation1$28
Lundbeck LLC1$22
Lilly USA, LLC1$19
Bayer Healthcare Pharmaceuticals Inc.1$17
Otsuka America Pharmaceutical, Inc.1$16

Products named: FARXIGA, VRAYLAR, REXULTI, Ozempic, AIRSUPRA, BREZTRI, LEQVIO, MOUNJARO.

Industry payments across MS — which companies pay providers there.